{"entity":{"type":"insider","cik":"0001744027","url":"/insider/0001744027","json_url":"/insider/0001744027.json","name":"PRESTRELSKI STEVEN","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":12,"n_filings":9,"first":"2019-01-02","last":"2022-02-24","span_basis":"filed_date"},"name_variants":[{"name":"PRESTRELSKI STEVEN","source":"filing","n_filings":9,"first_seen":"2019-01-02","last_seen":"2022-02-24"}],"transactions":[{"id":6192924,"accession":"0001867096-22-000025","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001867096-22-000025","line_url":"/filing/0001867096-22-000025#line-2","is_derivative":false,"issuer_cik":"0001744027","issuer_name":"Xeris Biopharma Holdings, Inc.","issuer_ticker":"XERS","issuer_name_source":null,"issuer_url":"/issuer/0001744027","owner_cik":"0001744027","owner_name":"PRESTRELSKI STEVEN","owner_display_name":"PRESTRELSKI STEVEN","owner_url":"/insider/0001744027","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":11228.0,"shares_display":"11,228","price_per_share":2.4188,"price_display":"2.42","price_state":"stated","total_value":27158.2864,"total_display":"27,158.29","total_whole":"27,158","shares_owned_after":569780.0,"shares_owned_after_display":"569,780","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-02-22","filed_date":"2022-02-24","scope":"insider"},{"id":4804618,"accession":"0001346302-21-000031","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001346302-21-000031","line_url":"/filing/0001346302-21-000031#line-1","is_derivative":false,"issuer_cik":"0001346302","issuer_name":"XERIS PHARMACEUTICALS INC","issuer_ticker":"XERS","issuer_name_source":null,"issuer_url":"/issuer/0001346302","owner_cik":"0001744027","owner_name":"PRESTRELSKI STEVEN","owner_display_name":"PRESTRELSKI STEVEN","owner_url":"/insider/0001744027","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":4.0725,"price_display":"4.07","price_state":"stated","total_value":40725.0,"total_display":"40,725.00","total_whole":"40,725","shares_owned_after":496824.0,"shares_owned_after_display":"496,824","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-04-12","filed_date":"2021-04-13","scope":"insider"},{"id":4353043,"accession":"0001346302-21-000004","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001346302-21-000004","line_url":"/filing/0001346302-21-000004#line-1","is_derivative":false,"issuer_cik":"0001346302","issuer_name":"XERIS PHARMACEUTICALS INC","issuer_ticker":"XERS","issuer_name_source":null,"issuer_url":"/issuer/0001346302","owner_cik":"0001744027","owner_name":"PRESTRELSKI STEVEN","owner_display_name":"PRESTRELSKI STEVEN","owner_url":"/insider/0001744027","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":6.0058,"price_display":"6.01","price_state":"stated","total_value":60058.0,"total_display":"60,058.00","total_whole":"60,058","shares_owned_after":406824.0,"shares_owned_after_display":"406,824","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-01-13","filed_date":"2021-01-15","scope":"insider"},{"id":5270057,"accession":"0001346302-21-000002","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001346302-21-000002","line_url":"/filing/0001346302-21-000002#line-1","is_derivative":false,"issuer_cik":"0001346302","issuer_name":"XERIS PHARMACEUTICALS INC","issuer_ticker":"XERS","issuer_name_source":null,"issuer_url":"/issuer/0001346302","owner_cik":"0001744027","owner_name":"PRESTRELSKI STEVEN","owner_display_name":"PRESTRELSKI STEVEN","owner_url":"/insider/0001744027","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":5.7244,"price_display":"5.72","price_state":"stated","total_value":57244.0,"total_display":"57,244.00","total_whole":"57,244","shares_owned_after":416824.0,"shares_owned_after_display":"416,824","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-01-11","filed_date":"2021-01-12","scope":"insider"},{"id":2281256,"accession":"0000899243-20-001167","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-20-001167","line_url":"/filing/0000899243-20-001167#line-1","is_derivative":false,"issuer_cik":"0001346302","issuer_name":"XERIS PHARMACEUTICALS INC","issuer_ticker":"XERS","issuer_name_source":null,"issuer_url":"/issuer/0001346302","owner_cik":"0001744027","owner_name":"PRESTRELSKI STEVEN","owner_display_name":"PRESTRELSKI STEVEN","owner_url":"/insider/0001744027","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":5.4992,"price_display":"5.50","price_state":"stated","total_value":54992.0,"total_display":"54,992.00","total_whole":"54,992","shares_owned_after":421824.0,"shares_owned_after_display":"421,824","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-01-13","filed_date":"2020-01-14","scope":"insider"},{"id":7775838,"accession":"0000899243-19-025613","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000899243-19-025613","line_url":"/filing/0000899243-19-025613#line-4","is_derivative":false,"issuer_cik":"0001346302","issuer_name":"XERIS PHARMACEUTICALS INC","issuer_ticker":"XERS","issuer_name_source":null,"issuer_url":"/issuer/0001346302","owner_cik":"0001744027","owner_name":"PRESTRELSKI STEVEN","owner_display_name":"PRESTRELSKI STEVEN","owner_url":"/insider/0001744027","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":7.9746,"price_display":"7.97","price_state":"stated","total_value":79746.0,"total_display":"79,746.00","total_whole":"79,746","shares_owned_after":449324.0,"shares_owned_after_display":"449,324","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-10-11","filed_date":"2019-10-16","scope":"insider"},{"id":7775837,"accession":"0000899243-19-025613","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000899243-19-025613","line_url":"/filing/0000899243-19-025613","is_derivative":false,"issuer_cik":"0001346302","issuer_name":"XERIS PHARMACEUTICALS INC","issuer_ticker":"XERS","issuer_name_source":null,"issuer_url":"/issuer/0001346302","owner_cik":"0001744027","owner_name":"PRESTRELSKI STEVEN","owner_display_name":"PRESTRELSKI STEVEN","owner_url":"/insider/0001744027","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":12.0395194,"price_display":"12.04","price_state":"stated","total_value":120395.194,"total_display":"120,395.19","total_whole":"120,395","shares_owned_after":459362.0,"shares_owned_after_display":"459,362","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-07-11","filed_date":"2019-10-16","scope":"insider","n_lines":2},{"id":7830680,"accession":"0000899243-19-010607","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-19-010607","line_url":"/filing/0000899243-19-010607#line-1","is_derivative":false,"issuer_cik":"0001346302","issuer_name":"XERIS PHARMACEUTICALS INC","issuer_ticker":"XERS","issuer_name_source":null,"issuer_url":"/issuer/0001346302","owner_cik":"0001744027","owner_name":"PRESTRELSKI STEVEN","owner_display_name":"PRESTRELSKI STEVEN","owner_url":"/insider/0001744027","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":9.5649,"price_display":"9.56","price_state":"stated","total_value":95649.0,"total_display":"95,649.00","total_whole":"95,649","shares_owned_after":477024.0,"shares_owned_after_display":"477,024","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-04-11","filed_date":"2019-04-12","scope":"insider"},{"id":7775834,"accession":"0000899243-19-025613","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-19-025613","line_url":"/filing/0000899243-19-025613#line-1","is_derivative":false,"issuer_cik":"0001346302","issuer_name":"XERIS PHARMACEUTICALS INC","issuer_ticker":"XERS","issuer_name_source":null,"issuer_url":"/issuer/0001346302","owner_cik":"0001744027","owner_name":"PRESTRELSKI STEVEN","owner_display_name":"PRESTRELSKI STEVEN","owner_url":"/insider/0001744027","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7700.0,"shares_display":"7,700","price_per_share":17.2025,"price_display":"17.20","price_state":"stated","total_value":132459.25,"total_display":"132,459.25","total_whole":"132,459","shares_owned_after":469324.0,"shares_owned_after_display":"469,324","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-01-14","filed_date":"2019-10-16","scope":"insider"},{"id":8021841,"accession":"0000899243-19-001206","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-19-001206","line_url":"/filing/0000899243-19-001206#line-1","is_derivative":false,"issuer_cik":"0001346302","issuer_name":"XERIS PHARMACEUTICALS INC","issuer_ticker":"XERS","issuer_name_source":null,"issuer_url":"/issuer/0001346302","owner_cik":"0001744027","owner_name":"PRESTRELSKI STEVEN","owner_display_name":"PRESTRELSKI STEVEN","owner_url":"/insider/0001744027","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2300.0,"shares_display":"2,300","price_per_share":null,"price_display":null,"price_state":"not-stated","total_value":null,"total_display":null,"total_whole":null,"shares_owned_after":487024.0,"shares_owned_after_display":"487,024","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-01-11","filed_date":"2019-01-15","scope":"insider"},{"id":8143294,"accession":"0000899243-19-000160","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-19-000160","line_url":"/filing/0000899243-19-000160#line-2","is_derivative":false,"issuer_cik":"0001346302","issuer_name":"XERIS PHARMACEUTICALS INC","issuer_ticker":"XERS","issuer_name_source":null,"issuer_url":"/issuer/0001346302","owner_cik":"0001744027","owner_name":"PRESTRELSKI STEVEN","owner_display_name":"PRESTRELSKI STEVEN","owner_url":"/insider/0001744027","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":15720.0,"shares_display":"15,720","price_per_share":15.823,"price_display":"15.82","price_state":"stated","total_value":248737.56,"total_display":"248,737.56","total_whole":"248,738","shares_owned_after":489324.0,"shares_owned_after_display":"489,324","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-12-26","filed_date":"2019-01-02","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":12,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":12,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":12},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001867096","name":"Xeris Biopharma Holdings, Inc.","url":"/issuer/0001867096","role":"Officer (Chief Scientific Officer)","n_filings":1,"first_seen":"2022-02-24","last_seen":"2022-02-24"},{"type":"issuer","type_label":"ISSUER","cik":"0001346302","name":"XERIS PHARMACEUTICALS INC","url":"/issuer/0001346302","role":"Officer (Chief Scientific Officer)","n_filings":8,"first_seen":"2019-01-02","last_seen":"2021-04-13"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001744027","retrieved_at":"2026-08-25T10:40:53+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-24","last_ingest":"2026-08-25T05:24:19.374141+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}